Literature DB >> 26694494

Epidemiology, outcomes, and predictors of mortality in hospitalized adults with Clostridium difficile infection.

Sahil Khanna1, Arjun Gupta2,3, Larry M Baddour2,4, Darrell S Pardi5.   

Abstract

Studies have demonstrated an increasing Clostridium difficile infection (CDI) incidence in hospitals and the community, with increasing morbidity and mortality. In this study, we analyzed data from the National Hospital Discharge Survey (NHDS) to evaluate CDI epidemiology, outcomes, and predictors of mortality in hospitalized adults. We identified cases of CDI (and associated comorbid conditions) from NHDS data from 2005 through 2009 using ICD-9 codes. Weighted univariate and multivariate analyses were performed to ascertain CDI incidence, associations between CDI and outcomes [length of stay (LOS), colectomy, all-cause in-hospital mortality, and discharge to a care facility], and predictors of all-cause in-hospital mortality. Of an estimated 162 million adult inpatients, 1.26 million (0.8 %) had CDI. The overall CDI incidence is 77.8/10,000 hospitalizations, with no statistically significant change over the study period. On multivariate analysis, after adjusting for age, gender, and comorbid conditions, CDI is an independent predictor of longer LOS (mean difference, 2.35 days), all-cause mortality [odds ratio (OR) 1.45], colectomy (OR 1.41), and discharge to a care facility (OR 2.12) (all P < 0.001). Elderly patients have a higher CDI incidence and worse outcomes than younger adults. The strongest predictors of all-cause mortality in patients with CDI include age 65 years or older, colectomy, and coagulation abnormalities. Despite stable CDI incidence and advances in management, CDI is associated with increased LOS, colectomy, all-cause in-hospital mortality, and discharge to a care facility in hospitalized, especially elderly, adults. Age older than 65 years should be added to the severity criteria for CDI.

Entities:  

Keywords:  Clostridium difficile infection; Diarrhea; Epidemiology; Mortality; Outcomes research

Mesh:

Year:  2015        PMID: 26694494     DOI: 10.1007/s11739-015-1366-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  50 in total

1.  Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals.

Authors:  A Le Monnier; A Duburcq; J-R Zahar; S Corvec; T Guillard; V Cattoir; P-L Woerther; V Fihman; V Lalande; H Jacquier; A Mizrahi; E Farfour; P Morand; G Marcadé; S Coulomb; E Torreton; F Fagnani; F Barbut
Journal:  J Hosp Infect       Date:  2015-07-22       Impact factor: 3.926

2.  Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.

Authors:  Jacques Pépin; Louis Valiquette; Benoit Cossette
Journal:  CMAJ       Date:  2005-09-22       Impact factor: 8.262

3.  Increasing rates in Clostridium difficile infection (CDI) among hospitalised patients, Spain 1999-2007.

Authors:  A Asensio; J Vaque-Rafart; F Calbo-Torrecillas; J J Gestal-Otero; F López-Fernández; A Trilla-Garcia; R Canton
Journal:  Euro Surveill       Date:  2008-07-31

Review 4.  The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2010-08       Impact factor: 3.869

5.  Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada.

Authors:  Jacques Pepin; Marie-Eve Alary; Louis Valiquette; Evelyne Raiche; Joannie Ruel; Katalin Fulop; Dominique Godin; Claude Bourassa
Journal:  Clin Infect Dis       Date:  2005-04-25       Impact factor: 9.079

6.  Clinical factors associated with development of severe-complicated Clostridium difficile infection.

Authors:  Raina Shivashankar; Sahil Khanna; Patricia P Kammer; W Scott Harmsen; Alan R Zinsmeister; Larry M Baddour; Darrell S Pardi
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-20       Impact factor: 11.382

7.  Costs of nosocomial Clostridium difficile-associated diarrhoea.

Authors:  R-P Vonberg; C Reichardt; M Behnke; F Schwab; S Zindler; P Gastmeier
Journal:  J Hosp Infect       Date:  2008-07-07       Impact factor: 3.926

8.  Rising economic impact of clostridium difficile-associated disease in adult hospitalized patient population.

Authors:  Xiaoyan Song; John G Bartlett; Kathleen Speck; April Naegeli; Karen Carroll; Trish M Perl
Journal:  Infect Control Hosp Epidemiol       Date:  2008-09       Impact factor: 3.254

9.  Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study.

Authors:  Denise Gravel; Mark Miller; Andrew Simor; Geoffrey Taylor; Michael Gardam; Allison McGeer; James Hutchinson; Dorothy Moore; Sharon Kelly; David Boyd; Michael Mulvey
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

10.  Multistate point-prevalence survey of health care-associated infections.

Authors:  Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

View more
  7 in total

1.  What do visitors know and how do they feel about contact precautions?

Authors:  Grace Seibert; Tola Ewers; Anna K Barker; Adam Slavick; Marc-Oliver Wright; Linda Stevens; Nasia Safdar
Journal:  Am J Infect Control       Date:  2017-07-18       Impact factor: 2.918

2.  Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.

Authors:  Dipesh Solanky; Darrell S Pardi; Edward V Loftus; Sahil Khanna
Journal:  Inflamm Bowel Dis       Date:  2019-02-21       Impact factor: 5.325

3.  Predictors of Mortality Among a National Cohort of Veterans With Recurrent Clostridium difficile Infection.

Authors:  Haley J Appaneal; Aisling R Caffrey; Maya Beganovic; Sanja Avramovic; Kerry L LaPlante
Journal:  Open Forum Infect Dis       Date:  2018-07-19       Impact factor: 3.835

4.  Surveillance of Clostridium difficile Infections: Results from a Six-Year Retrospective Study in Nine Hospitals of a North Italian Local Health Authority.

Authors:  Greta Roncarati; Laura Dallolio; Erica Leoni; Manuela Panico; Angela Zanni; Patrizia Farruggia
Journal:  Int J Environ Res Public Health       Date:  2017-01-10       Impact factor: 3.390

5.  Identifying predictive features of Clostridium difficile infection recurrence before, during, and after primary antibiotic treatment.

Authors:  Sepideh Pakpour; Amit Bhanvadia; Roger Zhu; Abhimanyu Amarnani; Sean M Gibbons; Thomas Gurry; Eric J Alm; Laura A Martello
Journal:  Microbiome       Date:  2017-11-13       Impact factor: 14.650

6.  Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis.

Authors:  Alexandre R Marra; Eli N Perencevich; Richard E Nelson; Matthew Samore; Karim Khader; Hsiu-Yin Chiang; Margaret L Chorazy; Loreen A Herwaldt; Daniel J Diekema; Michelle F Kuxhausen; Amy Blevins; Melissa A Ward; Jennifer S McDanel; Rajeshwari Nair; Erin Balkenende; Marin L Schweizer
Journal:  JAMA Netw Open       Date:  2020-01-03

7.  Clinical complications in patients with primary and recurrent Clostridioides difficile infection: A real-world data analysis.

Authors:  Paul Feuerstadt; Mena Boules; Laura Stong; David N Dahdal; Naomi C Sacks; Kathleen Lang; Winnie W Nelson
Journal:  SAGE Open Med       Date:  2021-01-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.